SUAB Webinar: Reflecting on covid-19 and substance use
Event Information
About this Event
In the first of the SUAB webinar series, Michael Linnell and Peter Furlong will reflect on the impact of covid-19 on those who use substances, and the services and practitioners who support them.
This is a free event.
A zoom link will be emailed to attendees at 12pm on July 7th.
Michael Linnell
Presentation title: What will the ‘New Normal’ look like: Drug Services, Drug markets, Hotels for the Homeless and other random observations about the lockdown.
About Michael:
Michael did his first degree in fine art and his MSc in Health Education. He once earned a living as a comedy acrobat but has worked in the drugs field for over 35 years. He was Director of Communications for Lifeline for 25 years where he produced hundreds of research led harm reduction publications. He set up his own business in 2014 and currently manages the Local Drug Information Systems for Greater Manchester, Lancashire and Cumbria, is coordinator of UK and Ireland DrugWatch, works on drug trend research, produces publications and animations and is a volunteer with The Loop.
Peter Furlong
Presentation title: Drug and Alcohol services responses to Covid-19 and future service provision.
About Peter:
Peter is the North West Development Manager & Harm Reduction lead for Change Grow Live (CGL). He has has worked in voluntary sector drug services for over 22 years. He started working as a volunteer for Merseyside Drugs Council (MDC) in Bootle around 1996 while completing his PHD (Private Hire Driver), Peter then started work in the Maryland Centre in Liverpool in 1998 focusing on outreach for hard to reach groups and then moved back to Sefton as a full time outreach worker with MDC, latterly Lighthouse Project. Prior to his current regional role for CGL, Peter managed Sefton Integrated Drug Treatment Services and other front-line roles including Needle Exchange, Drug Worker, Team Leader & Project Manager. His current work includes developing Peer to Peer Naloxone initiatives and he has recently led on the pilots for Nasal Naloxone (Nyxoid) in the North West.
